Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus

Código QR

Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus

Aim. To investigate the association of variation in lipid-lowering response and endothelial function (EF) parameters after atorvastatin therapy in patients with type 2 diabetes mellitus (T2DM) with genetic markers of atherosclerosis.Methods. We included 97 patients with T2DM who were prescribed ator...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nadezhda O. Lebedeva, Olga K. Vikulova, Alexei G. Nikitin, Minara Sh. Shamkhalova, Marina V. Shestakova, Ivan I. Dedov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2016
Materias:	statins endothelial function t2d polymorphic markers genes pparg2 apoe tnf-α Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/036503a760eb48cb90d3b24cb9ff6ded
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Frequency of Common Variants in Genes Involved in Lipid-Lowering Response to Statins in Chilean Subjects with Hypercholesterolemia
por: Rosales,Alexy, et al.
Publicado: (2011)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: A. N. Silkov, et al.
Publicado: (2014)

Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

FUNCTIONAL POLYMORPHISM OF THE PRO-INFLAMMATORY CYTOKINE GENES IN PULMONARY TUBERCULOSIS
por: E. G. Churina, et al.
Publicado: (2019)

PROMOTER REGION rs1800629 TNFα POLYMORPHISM AND ITS INFLUENCE ON TUMOR NECROSIS FACTOR ALPHA CONCENTRATION IN BLOOD OF HEALTHY INDIVIDUALS AND PATIENTS WITH ERYSIPELAS
por: A. S. Emelyanov, et al.
Publicado: (2018)

ASSOCIATION OF LETHAL OUTCOMES IN SURGICAL SEPSIS WITH ALLELIC VARIANTS OF TNF Α AND HEAT SHOCK PROTEIN (HSP70-2) GENES
por: A. V. Shevchenko, et al.
Publicado: (2014)

Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
por: John N. Booth, et al.
Publicado: (2018)

GENETIC POLYMORPHISMS OF CD14, TNFα AND FCGR2A IN THE PATIENTS WITH INFLUENZA A H1N1 IN TRANSBAIKALIA REGION
por: V. V. Petrov, et al.
Publicado: (2014)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
por: A. A. Alshevskaya, et al.
Publicado: (2012)

Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)

Cerebrovascular Disease and Statins
por: Luis M. Beltrán Romero, et al.
Publicado: (2021)

Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012)

Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
por: Lv P, et al.
Publicado: (2020)

Distinctive roles of tumor necrosis factor receptor type 1 and type 2 in a mouse disc degeneration model
por: Shanzheng Wang, et al.
Publicado: (2021)

Statins and diabetes mellitus: price of collaboration
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2012)

STAT3 and Nrf2 pathways modulate the protective effect of verapamil on lung injury of diabetic rats
por: Mohamed Mervat Z., et al.
Publicado: (2018)

NETWORK APPROACH TO ANALYSIS OF QUANTITATIVE TRAIT LOCI FOR TUMOR NECROSIS FACTOR (TNFα-863, TNFα-308, TNFα-238), VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF-2578, VEGF+936) AND MATRIX METALLOPROTEINASE (ММР2-1306, ММР3-1171, ММР9-1569) GENES IN AGERELATED MACULAR DEGENERATION
por: A. V. Shevchenko, et al.
Publicado: (2017)

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
por: Michael G. Nanna, et al.
Publicado: (2018)

SIMULTANEOUS QUANTITATION OF MOXIFLOXACIN AND STATINS INAPI BY RP-HPLC
por: Qamar,Fatima, et al.
Publicado: (2019)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

TNF-α (−308) Gene Polymorphism and Type 2 Diabetes Mellitus in Ethiopian Diabetes Patients
por: Ayelign B, et al.
Publicado: (2019)

EFFECTS OF STATINS UPON ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN IN VITRO STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

The apolipoprotein receptor LRP3 compromises APP levels
por: Inmaculada Cuchillo-Ibañez, et al.
Publicado: (2021)

El tratamiento con atorvastatina reduce la actividad de xantina-oxidasa unida al endotelio en pacientes con insuficiencia cardíaca crónica: ¿Un posible nuevo efecto pleiotrópico?
por: Alcaíno,Hernán, et al.
Publicado: (2009)

Evaluation of Vascular Endothelial Function in Children with Type 1 Diabetes Mellitus
por: Karolina Nocuń-Wasilewska, et al.
Publicado: (2021)

Association of polymorphisms of the ADIPOQ, ADIPOR1 and ADIPOR2 genes with type 2 diabetes mellitus
por: Dmitry Sergeevich Khodyrev, et al.
Publicado: (2015)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Lidia Cobos-Palacios, et al.
Publicado: (2021)

Risk of chronic kidney disease in type 2 diabetes determined by polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes as compound effect of risk genotypes combination
por: Anna Viktorovna Zheleznyakova, et al.
Publicado: (2014)

EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Multiple imputation procedures allow the rescue of missing data: An application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy
por: SCHIATTINO,IRENE, et al.
Publicado: (2005)

Association between the use of statins and periodontal status: a review
por: Rosenberg,David R, et al.
Publicado: (2019)

Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review
por: Behzad Heidari, et al.
Publicado: (2021)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Sergio Jansen-Chaparro, et al.
Publicado: (2021)

Polymorphic gene markers ILRA and IL2: population distinctions in association with diabetes mellitus
por: Olga Igorevna Kopylova, et al.
Publicado: (2012)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
por: Thongtang N, et al.
Publicado: (2020)

ACUTE PHASE OF SYSTEMIC INFLAMMATORY RESPONSE FOLLOWING A SINGLE-PORT LAPAROSCOPIC CHOLECYSTECTOMY
por: A. V. Alekberzade, et al.
Publicado: (2016)

SIMULTANEOUS DETERMINATION OF ENALAPRIL AND STATIN'S IN PHARMACEUTICAL FORMULATIONS BY RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2011)

Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
por: Victoriya N. Serebryakova, et al.
Publicado: (2021)

An overview of the biological disease modifying drugs available for arthritic conditions in South Africa
por: Leonie Harmse, et al.
Publicado: (2016)

EFFECTS OF SYNTETIC CANNABINOID RECEPTOR LIGANDS WIN 55.212-2 AND ANANDAMID UPON IN VITRO ACTIVITY OF IMMUNOCOMPETENT CELLS
por: E. G. Lobanova
Publicado: (2014)